Home

Download

Statistics

Landscape

Help

Contact

	Gene summary
	Datasets with differential expression of this gene
	Expression of this gene in the resistant group across all datasets and cell types
	Significant ligand-receptor pairs related to this gene (This gene does not contain this module)
	Known drug resistance mechanisms of this gene (This gene does not contain this module)
	MicroRNAs (miRNAs) regulating this gene
	Motifs and transcription factors (TFs) regulating this gene
	Acts as a transcription factor (This gene does not contain this module)
	Acts as a drug target< (This gene does not contain this module)

Gene: CLDN12

Summary for CLDN12

Gene information	Gene symbol	CLDN12
	Ensembl ID	ENSG00000157224
	Entrez ID	9069
	Gene name	claudin 12
	Synonyms	NA
	Gene type	protein_coding
	UniProtAcc	NA

Top

Dataset with differentially expressed gene: CLDN12

Differentially expression genes between the resistant and sensitive groups. A positive avg_log2FC represents significantly high expression in the resistant group, while a negative avg_log2FC represents significantly low expression in the resistant group.

Dataset	Source	Tissue	Cancer type level1	Cancer type level2	Drug type	Regimen	Timepoint	Cell type	avg_log2FC	p_val_adj
GSE140440	DU145 and PC cell lines	Cell line	Prostate cancer	Prostate cancer	Chemotherapy	docetaxel	NA	Malignant cells	1.5645	2.38e-11
GSE139386	H3122 cell line	Cell line	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	ceritinib	NA	Malignant cells	0.31554	0.00e+00
GSE168668	LNCaP cell line	Cell line	Prostate cancer	Prostate cancer	Targeted therapy	enzalutamide	NA	Malignant cells	-0.410633	0.00e+00
GSE175716	PDX	Tumor tissue	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	sorafenib	NA	Malignant cells	-0.539483	0.00e+00

Top

Expression of CLDN12 in the resistant group across all datasets and cell types

Red dots represent significantly high expression in the resistant group, while blue dots represent significantly low expression in the resistant group. White dots represent that there is no significant difference in the expression of this gene between the resistant and sensitive groups. Blank represents that this cell type is not present in this dataset. (If the image exists, the user can click on it to enlarge it in a new window.)

Top

Significant ligand-receptor pairs related to CLDN12

This table shows the significant ligand-receptor pairs related to this gene across all datasets, timepoints and conditions. (Complete files can be downloaded from the download section.)

Top

Known drug resistance mechanisms of this gene

This table shows the known drug resistance mechanisms of this gene. Clicking on this gene will link to another database that displays more drug resistance-related information.

Top

MicroRNAs (miRNA) regulating CLDN12

This table shows the miRNAs with a score of more than 80 regulating this gene. (Complete files can be downloaded from the download section.)

Gene symbol	miRNA	Score	GeneBank accession
CLDN12	hsa-miR-548ay-5p	87.3373	NM_001185072
CLDN12	hsa-miR-548b-5p	87.3373	NM_001185072
CLDN12	hsa-miR-548bb-5p	87.3373	NM_001185072
CLDN12	hsa-miR-373-5p	87.2704	NM_001185072
CLDN12	hsa-miR-371b-5p	87.2704	NM_001185072
CLDN12	hsa-miR-302c-5p	87.1247	NM_001185072
CLDN12	hsa-miR-559	87.0053	NM_001185072
CLDN12	hsa-miR-216a-5p	86.3801	NM_001185072
CLDN12	hsa-miR-676-5p	85.8637	NM_001185072
CLDN12	hsa-miR-6787-3p	85.8139	NM_001185072
CLDN12	hsa-miR-6824-5p	85.0433	NM_001185072
CLDN12	hsa-miR-5003-3p	84.9855	NM_001185072
CLDN12	hsa-miR-9986	84.2748	NM_001185072
CLDN12	hsa-miR-1294	84.2748	NM_001185072
CLDN12	hsa-miR-4721	84.1288	NM_001185072
CLDN12	hsa-miR-3143	84.0295	NM_001185072
CLDN12	hsa-let-7c-3p	83.0089	NM_001185072
CLDN12	hsa-miR-15a-5p	82.6397	NM_001185072
CLDN12	hsa-miR-16-5p	82.6397	NM_001185072
CLDN12	hsa-miR-195-5p	82.6397	NM_001185072
CLDN12	hsa-miR-15b-5p	82.6397	NM_001185072
CLDN12	hsa-miR-548j-5p	82.3686	NM_001185072
CLDN12	hsa-miR-548ab	82.3686	NM_001185072
CLDN12	hsa-miR-548ap-5p	82.3686	NM_001185072
CLDN12	hsa-miR-548ar-5p	82.3686	NM_001185072
CLDN12	hsa-miR-548i	82.3686	NM_001185072
CLDN12	hsa-miR-548a-5p	82.3686	NM_001185072
CLDN12	hsa-miR-548y	82.3686	NM_001185072
CLDN12	hsa-miR-6516-5p	82.2552	NM_001185072
CLDN12	hsa-miR-3160-5p	82.1492	NM_001185072
CLDN12	hsa-miR-548aq-5p	82.0317	NM_001185072
CLDN12	hsa-miR-4789-5p	81.2443	NM_001185072
CLDN12	hsa-miR-144-5p	80.9438	NM_001185072

Page: 1 2

Top

Motifs and transcription factors (TFs) regulating CLDN12

This table shows the Motifs and transcription factors (TFs) regulating this gene. (Complete files can be downloaded from the download section.)

Gene symbol	motif	TF_highConf
CLDN12	transfac_pro__M06035	ZNF749 (directAnnotation).

Page: 1

Top

Acts as a transcription factor

This table shows that this differential gene acts as a transcription factor.

Top

Acts as a drug target

This table shows that this differential gene acts as a drug target.

1	"Sun X, Zhang Y, Li H, Zhou Y, Shi S, Chen Z, He X, Zhang H, Li F, Yin J, Mou M, Wang Y, Qiu Y, Zhu F. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Res. 2023 Jan 6;51(D1):D1263-D1275. doi: 10.1093/nar/gkac812. PMID: 36243960; PMCID: PMC9825618."
2	"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037. PMID: 29126136; PMCID: PMC5753335."